SN
Sangeeta N. Bhatia
Founder of Ropirio Therapeutics
Cambridge, Massachusetts
Overview
Sangeeta N. Bhatia is an MIT Professor and Entrepreneur based in Cambridge, Massachusetts, known for her role as the Director of the Marble Center for Cancer Nanomedicine. She has co-founded multiple successful biotech companies and serves on the boards of prestigious organizations like Brown University and Vertex Pharmaceuticals.
With a diverse educational background including a Doctor of Medicine from Harvard Medical School and a PhD from MIT, Sangeeta N. Bhatia has made significant contributions to the fields of drug delivery and diagnostics. Her entrepreneurial ventures and leadership positions in various biotech companies showcase her expertise and influence in the industry.
Work Experience
Professor, Director Marble Center for Cancer Nanomedicine
2005 - Current
Co-Founder
2023
Co-Founder
2023
Co-Founder
2023
Co-Founder
2022
Co-Founder
2020
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Raised $101,470,989.00 from Section 32, aMoon Fund, Polaris Partners, Waterman Ventures, Lightspeed Venture Partners, Alumni Ventures and Catalio Capital Management.
Co-Founder
2015
Fellow, Board of Trustees
2015
Member Board of Directors
2015
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Raised $657,308,360.00 from J.P. Morgan Securities Inc., Bank of America Merrill Lynch, Morgan Stanley, Goldman Sachs and Janssen Belgium.
Co-Founder, Hepregen
2008 - 2018
BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Raised $45,000,000.00 from Thompson Street Capital Partners and NXT Capital.